AIP
LXEO icon

Ameritas Investment Partners’s Lexeo Therapeutics LXEO Stock Holding History

Ameritas Investment Partners’s Portfolio LXEO Stock Details LXEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29.4K Hold
5,121
– – ﹤0.01% 2407
2025
Q4 		$50.9K Buy
5,121
+2,734
+115% +$24.9K ﹤0.01% 2104
2025
Q3 		$15.8K Hold
2,387
– – ﹤0.01% 2773
2025
Q2 		$9.6K Hold
2,387
– – ﹤0.01% 2993
2025
Q1 		$8.28K Hold
2,387
– – ﹤0.01% 2874
2024
Q4 		$15.7K Hold
2,387
– – ﹤0.01% 2730
2024
Q3 		$21.6K Buy
2,387
+1,364
+133% +$16.3K ﹤0.01% 2617
2024
Q2 		$16.4K Hold
1,023
– – ﹤0.01% 2701
2024
Q1 		$16K Buy
+1,023
New +$16K ﹤0.01% 2653

Other funds holding LXEO

PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameritas Investment Partners's LXEO Position: Q1 2026 in Review

Ameritas Investment Partners held its Lexeo Therapeutics (LXEO) position steady in Q1 2026 at 5,121 shares worth $29.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2407.

Ameritas Investment Partners first reported a position in LXEO in Q1 2024 and has held it in 9 quarters since. The position peaked at $50.9K in Q4 2025. 139 funds tracked by Wall St. Rank hold LXEO as of Q1 2026.

  • Ameritas Investment Partners held 5,121 shares of Lexeo Therapeutics worth $29.4K as of Q1 2026.
  • Ameritas Investment Partners left its Lexeo Therapeutics share count unchanged in Q1 2026.
  • Lexeo Therapeutics made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2407 holding.
  • Ameritas Investment Partners first reported a position in Lexeo Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • Ameritas Investment Partners's Lexeo Therapeutics position peaked at $50.9K in Q4 2025.
  • 139 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.